Spaceseq Medical Laboratory successfully passed the inter-room quality evaluation of National Center for Clinical Laboratories with 7 projects perfect scores!

Recently, the National Center for Clinical Laboratories (NCCL) released the "2023 National Clinical Laboratory Quality Evaluation Report".

According to the report, "BRAF mutation test", "EGFR mutation test", "KRAS mutation test" and "KRAS mutation test" participated by Xiamen Spaceseq Medical Testing Laboratory Co. (hereinafter referred to as "Sapceseq Medical Laboratory") passed the 7 inter-laboratory quality assessment projects, including "BRAF mutation test", "EGFR mutation test", "KRAS mutation test" and "tumor free DNA EGFR mutation test", with excellent results.

Spaceseq Test Report List：

1. Tumor free DNA EGFR mutation test inter-room quality evaluation results

2. BRAF mutation test inter-room quality evaluation results

3. EGFR mutation test inter-room quality evaluation results

4. KRAS mutation test inter-room quality evaluation results

5. Warfarin drug metabolism gene polymorphism inter-room quality evaluation results

6. Irinotecan drug metabolism gene (UGT1A1) polymorphism inter-room quality evaluation results

7.Clopidogrel drug metabolism gene (CYP2C19) polymorphism inter-room quality evaluation results

The inter-laboratory quality assessment of the National Health and Health Commission Clinical Laboratory Center is an important basis for the quality level of testing laboratories and an authoritative standard for evaluating the quality of domestic laboratory tests. Passing all 7 inter-laboratory quality assessments with perfect scores shows that the quality management system, experimental technology, bioinformatics analysis capability, clinical interpretation standardization and accuracy of SpaceSeq Medical Inspection have all met the national standards, demonstrating once again SpaceGen Medical Inspection's scientific and rigorous management standard and quality-first testing principle.

Since its establishment, SpaceSeq has actively participated in more than 100 inter-laboratory quality assessments organized by domestic and international authorities, with excellent results. As a leader in the field of precision medicine, SpaceSeq Medical has always been committed to rigorous scientific testing, providing expertise to assist clinicians in diagnosing, evaluating drug efficacy, and improving patient prognosis.

About NCCL

The National Center for Clinical Laboratories (NCCL) was established in 1982 at the Beijing Hospital of the Ministry of Health, with the main direction of clinical test quality control and improvement. NCCL is responsible for national clinical test quality management and control entrusted by the Ministry of Health, running the national clinical test inter-laboratory quality evaluation program, establishing and applying the clinical test reference system, and carrying out relevant scientific research.

NCCL organizes national clinical test quality management and control activities, organizes inter-laboratory quality evaluation in national medical institutions, assists in the development of technical specifications and standards related to clinical test quality management and control, provides relevant work suggestions and advice, validation opinions, and implements clinical test quality management and control measures, etc.

NCCL conducts a national inter-laboratory quality evaluation program for major clinical tests, covering clinical biochemistry, immunology, hematology, microbiology, molecular biology, blood transfusion testing and other specialties, including about 315 tests, with more than 6,000 participating laboratories (including medical institutions, blood collection institutions, disease control institutions, international travel health care centers and in vitro diagnostic companies, etc.)